• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载活性氧(ROS)响应性分子开关的芬顿反应刺激纳米粒子用于 ROS 放大和三阴性乳腺癌治疗。

Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.

机构信息

School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.

出版信息

J Mater Chem B. 2019 Dec 7;7(45):7141-7151. doi: 10.1039/c9tb01702j. Epub 2019 Oct 30.

DOI:10.1039/c9tb01702j
PMID:31663577
Abstract

Triple-negative breast cancer (TNBC) is characterized by a high metastatic rate, which can seriously threaten women's health. ROS play an important role in tumor development and metastasis. Excessive ROS can induce tumor cell apoptosis and inhibit tumor cell metastasis. This study investigated Fenton-reaction-stimulative nanoparticles (P@P/H NPs) containing ROS-responsive molecular switches for antitumor metastasis by amplifying the ROS and activating the cascade biological reaction of ROS in tumor cells. Spheroidal P@P/H NPs exhibited a uniform size of 68.18 ± 0.29 nm, high drug cumulative release of 97.59% in response to HO at 24 h, and satisfactory cytotoxicity with the IC value of 0.50 ± 0.02 μg mL. The markedly elevated ROS level caused by P@P/H NPs generated an evident antitumor metastasis effect in vitro by facilitating the expressions of cytochrome c, caspase-9, and caspase-3 and blocking that of matrix metalloprotein 9 (MMP-9). Moreover, P@P/H NPs engendered an excellent tumor inhibition rate of 56.37% and antitumor metastasis effect in vivo. Therefore, P@P/H NPs could respond to HO in tumor cells to rapidly disassemble and further increase the ROS to induce antitumor metastasis via the Fenton reaction.

摘要

三阴性乳腺癌(TNBC)的转移率较高,严重威胁着女性的健康。ROS 在肿瘤的发生和转移中起着重要作用。过量的 ROS 可以诱导肿瘤细胞凋亡,抑制肿瘤细胞转移。本研究通过放大 ROS 并激活肿瘤细胞中 ROS 的级联生物反应,探讨了含有 ROS 响应分子开关的芬顿反应刺激纳米颗粒(P@P/H NPs)在抗肿瘤转移中的作用。球形 P@P/H NPs 的粒径为 68.18 ± 0.29nm,在 24 小时内对 HO 的药物累积释放率高达 97.59%,具有令人满意的细胞毒性,IC 值为 0.50 ± 0.02μg/mL。P@P/H NPs 产生的 ROS 水平显著升高,通过促进细胞色素 c、caspase-9 和 caspase-3 的表达并阻断基质金属蛋白酶 9(MMP-9)的表达,在体外产生了明显的抗肿瘤转移作用。此外,P@P/H NPs 在体内产生了高达 56.37%的肿瘤抑制率和抗肿瘤转移作用。因此,P@P/H NPs 可以在肿瘤细胞中对 HO 作出反应,迅速解体,并通过芬顿反应进一步增加 ROS,从而诱导抗肿瘤转移。

相似文献

1
Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.负载活性氧(ROS)响应性分子开关的芬顿反应刺激纳米粒子用于 ROS 放大和三阴性乳腺癌治疗。
J Mater Chem B. 2019 Dec 7;7(45):7141-7151. doi: 10.1039/c9tb01702j. Epub 2019 Oct 30.
2
Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide.杨梅素通过铁依赖性过氧化氢产生的活性氧诱导三阴性乳腺癌细胞凋亡。
Food Chem Toxicol. 2018 Aug;118:154-167. doi: 10.1016/j.fct.2018.05.005. Epub 2018 May 6.
3
Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment.基于用pH敏感分子开关修饰的聚合物和携带雷公藤红素与二茂铁的低分子量肝素的纳米颗粒用于乳腺癌治疗。
Int J Biol Macromol. 2021 Jul 31;183:2215-2226. doi: 10.1016/j.ijbiomac.2021.05.204. Epub 2021 Jun 9.
4
Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species.甲基乙二醛通过产生活性氧诱导三阴性乳腺癌细胞中的线粒体凋亡途径。
Mol Carcinog. 2017 Sep;56(9):2086-2103. doi: 10.1002/mc.22665. Epub 2017 May 22.
5
ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy.载阿霉素的 ROS 响应性半乳糖化纳米粒子用于三阴性乳腺癌治疗。
Int J Nanomedicine. 2023 Mar 22;18:1381-1397. doi: 10.2147/IJN.S396087. eCollection 2023.
6
Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.用多功能纳米颗粒的 CD44/neuropilin 双分子靶点治疗转移性三阴性乳腺癌。
Biomaterials. 2017 Aug;137:23-36. doi: 10.1016/j.biomaterials.2017.05.022. Epub 2017 May 13.
7
Silver-coated zero-valent iron nanoparticles enhance cancer therapy in mice through lysosome-dependent dual programed cell death pathways: triggering simultaneous apoptosis and autophagy only in cancerous cells.载银零价铁纳米颗粒通过溶酶体依赖性双重程序性细胞死亡途径增强小鼠的癌症治疗:仅在癌细胞中引发同时的细胞凋亡和自噬。
J Mater Chem B. 2020 May 14;8(18):4122-4131. doi: 10.1039/c9tb01477b. Epub 2020 Apr 8.
8
Inhibiting the proliferation, migration and invasion of triple negative breast cancer cells through anti-tumor human serum albumin nanoparticles loading aziditaxel as a novel taxane derivative.通过负载叠氮紫杉醇的抗肿瘤人血清白蛋白纳米粒抑制三阴性乳腺癌细胞的增殖、迁移和侵袭,叠氮紫杉醇为一种新型紫杉烷衍生物。
Pharmazie. 2017 Mar 1;72(3):152-160. doi: 10.1691/ph.2017.6146.
9
Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.人参皂苷 Rk1 诱导 MDA-MB-231 三阴性乳腺癌细胞周期停滞和凋亡。
Toxicology. 2019 Apr 15;418:22-31. doi: 10.1016/j.tox.2019.02.010. Epub 2019 Feb 21.
10
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.用于治疗小鼠三阴性乳腺癌肺转移的协同药物双靶点混合纳米颗粒。
Acta Pharmacol Sin. 2017 Jun;38(6):835-847. doi: 10.1038/aps.2016.166. Epub 2017 Feb 20.

引用本文的文献

1
Emerging Combinatorial Drug Delivery Strategies for Breast Cancer: A Comprehensive Review.乳腺癌新兴的联合药物递送策略:综述
Curr Drug Targets. 2025;26(5):331-349. doi: 10.2174/0113894501352081241211090911.
2
Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation.FexMoyS-PEG 纳米粒子在结直肠癌中的治疗潜力:通过 ROS-铁死亡-糖酵解调控的多模态方法。
J Nanobiotechnology. 2024 May 16;22(1):253. doi: 10.1186/s12951-024-02515-3.
3
Regulation of Tumor Apoptosis of -Derived Lanostane Triterpenes by AKT/PI3K and MAPK Signaling Pathways .
- 衍生的羊毛甾烷三萜通过 AKT/PI3K 和 MAPK 信号通路调节肿瘤细胞凋亡。
Nutrients. 2023 Oct 13;15(20):4360. doi: 10.3390/nu15204360.
4
Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer.用于三阴性乳腺癌治疗的靶向纳米载体的最新进展
Pharmaceutics. 2023 Jan 11;15(1):246. doi: 10.3390/pharmaceutics15010246.
5
Nanoparticles mediated tumor microenvironment modulation: current advances and applications.纳米颗粒介导的肿瘤微环境调控:当前进展与应用。
J Nanobiotechnology. 2022 Jun 14;20(1):274. doi: 10.1186/s12951-022-01476-9.
6
Chemodynamic nanomaterials for cancer theranostics.用于癌症治疗和诊断的化学动力学纳米材料。
J Nanobiotechnology. 2021 Jun 28;19(1):192. doi: 10.1186/s12951-021-00936-y.